Deanna L. Kirkpatrick

Davis Polk advised the lead book-running manager and representative of the underwriters in connection with its $101.9 million initial public offering of common stock of Jounce Therapeutics,…

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Tech Data Corporation of $500 million aggregate principal amount of its 3.700% senior…

Davis Polk advised the underwriters in connection with the offering of $1.25 billion aggregate principal amount of 1.625% U.S. dollar bonds due 2020 issued by Export Development Canada…

Davis Polk advised Computer Sciences Corporation in connection with the $2 billion senior unsecured term loan facilities provided to Everett SpinCo, Inc., a wholly owned subsidiary of…

Davis Polk advised the sole lead arranger and sole bookrunner, and the administrative agent, of a committed £625 million bridge loan facility to support the proposed public-to-private…

Davis Polk advised the underwriters in connection with the inaugural SEC-registered offering of $2.25 billion aggregate principal amount of 1.90% bonds due December 6, 2019, issued by the…

Davis Polk advised the lead arranger and administrative agent in connection with a $1.7 billion 364-day bridge term loan credit facility to Dr Pepper Snapple Group, Inc. Loans borrowed…

Davis Polk advised the joint book-running managers on an SEC-registered offering by Abbott Laboratories of $2.85 billion aggregate principal amount of 2.350% notes due 2019, $2.85 billion…

Davis Polk advised the underwriters in connection with the offering of $1 billion aggregate principal amount of 1.375% U.S. dollar bonds due 2021 issued by Export Development Canada. Export…

Davis Polk advised the lead dealer managers and the co-dealer managers in connection with a cash tender offer by Hess Corporation for any and all of its 8.125% notes due 2019 (the “Any and…